| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/22/1997 | CA2237841A1 A method of sequencing |
| 05/22/1997 | CA2237818A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 05/22/1997 | CA2237783A1 E6 binding proteins |
| 05/22/1997 | CA2237641A1 Glial cell line-derived neurotrophic factor receptors |
| 05/22/1997 | CA2237589A1 Method of quantifying tumour cells in a body fluid and a suitable test kit |
| 05/22/1997 | CA2237548A1 Crf analogs and their use in photoaffinity labeling of crf receptors |
| 05/22/1997 | CA2237528A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | CA2237392A1 Production of somatic mosaicism in mammals using a recombinatorial substrate |
| 05/22/1997 | CA2237329A1 Extraction system and method |
| 05/22/1997 | CA2237299A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 05/22/1997 | CA2237214A1 Plant gene involved in auxin related signalling pathways |
| 05/22/1997 | CA2236332A1 Treatment of diabetes with a glucokinase gene |
| 05/22/1997 | CA2236076A1 The transcriptional promoter of the obesity gene |
| 05/22/1997 | CA2235762A1 Integrated nucleic acid hybridization devices based upon active surface chemistry |
| 05/22/1997 | CA2235710A1 Type ix collagen and fragments thereof |
| 05/22/1997 | CA2235695A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 05/22/1997 | CA2235629A1 Method for gene transfer into target cells with retrovirus |
| 05/22/1997 | CA2235628A1 Hybrid factor viii with modified activity |
| 05/22/1997 | CA2235395A1 Ultrahigh resolution comparative nucleic acid hybridization to combed dna fibers |
| 05/22/1997 | CA2235334A1 Polyvalent anti-dengue vaccine |
| 05/22/1997 | CA2232876A1 Fas ligand fusion protein |
| 05/22/1997 | CA2210650A1 Cell cycle checkpoint pik-related kinase materials and methods |
| 05/21/1997 | EP0774518A2 Nucleic acid probes complementary to Human Papillomavirus nucleic acid and related methods and kits |
| 05/21/1997 | EP0774517A1 Method of individual discrimination by polymerase chain reaction using mi primer |
| 05/21/1997 | EP0774516A2 Fluorescence polarization detection of nucleic acid amplification |
| 05/21/1997 | EP0774515A2 Fluorescence polarization detection of nucleic acids |
| 05/21/1997 | EP0774513A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER |
| 05/21/1997 | EP0774512A2 A method for production of protein using molecular chaperon |
| 05/21/1997 | EP0774511A1 Methods of producing members of specific binding pairs |
| 05/21/1997 | EP0774510A1 Ungulate eg cell |
| 05/21/1997 | EP0774118A2 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 05/21/1997 | EP0774014A1 Methods for measuring telomere length |
| 05/21/1997 | EP0774013A1 Detection of mycobacteria |
| 05/21/1997 | EP0774009A1 Process for preparing viruses and viral vectors |
| 05/21/1997 | EP0774008A1 Adenovirus including a gene coding for a superoxide dismutase |
| 05/21/1997 | EP0774007A1 Production of oligosaccharides in transgenic plants |
| 05/21/1997 | EP0774006A2 Chimerical peptide-nucleic acid fragment, process for producing the same and its use for appropriately introducing nucleic acids into cell organelles and cells |
| 05/21/1997 | EP0774005A1 Surface expression of enzyme in gene directed prodrug therapy |
| 05/21/1997 | EP0774004A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 05/21/1997 | EP0774003A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 05/21/1997 | EP0774002A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 05/21/1997 | EP0774001A1 Production of tissue factor pathway inhibitor |
| 05/21/1997 | EP0774000A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 05/21/1997 | EP0773999A2 Or-1 on orphan receptor belonging to the nuclear receptor family |
| 05/21/1997 | EP0773998A1 Novel vesicular acetylcholine carrier |
| 05/21/1997 | EP0773997A2 Htk ligand |
| 05/21/1997 | EP0773996A1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 05/21/1997 | EP0773995A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof |
| 05/21/1997 | EP0773994A1 Receptor-ligand assay |
| 05/21/1997 | EP0773993A1 Genetically engineered swine cells |
| 05/21/1997 | EP0773991A1 Active calpain expressed by baculovirus |
| 05/21/1997 | EP0773989A1 Method for measuring hormones in biological samples |
| 05/21/1997 | EP0773962A1 Antibodies which activate an erythropoietin receptor |
| 05/21/1997 | EP0773960A1 POLYPEPTIDES WITH Fc BINDING ABILITY |
| 05/21/1997 | EP0773959A1 Adrenergic receptor |
| 05/21/1997 | EP0773957A2 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| 05/21/1997 | EP0773952A1 Interaction trap systems for detecting protein interactions |
| 05/21/1997 | EP0773950A1 Linked peptide nucleic acids |
| 05/21/1997 | EP0773785A2 Treatment of cancer using hsv mutant |
| 05/21/1997 | EP0746616A4 Expression of the glucose oxidase gene in transgenic organisms |
| 05/21/1997 | EP0679187B1 Process for recovering native, oligomeric, glycosylated ectodomains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 05/21/1997 | EP0660844A4 Isolated nucleotide sequences for identifying neisseria gonorrhoeae. |
| 05/21/1997 | EP0658195B1 Virus obtainable from human neuroblastoma cells |
| 05/21/1997 | EP0595948B1 Yeast strains with stable integration of heterologous genes |
| 05/21/1997 | EP0567587A4 Synthesis of full-length, double-stranded dna from a single-stranded linear dna template |
| 05/21/1997 | EP0557448A4 Preparation of nucleic acid samples |
| 05/21/1997 | EP0527821B1 Oxidation resistant thrombomodulin analogs |
| 05/21/1997 | EP0491875B1 Recombinant dna method and vectors for use therein |
| 05/21/1997 | EP0415958B1 A p1 bacteriophage cloning system for dna fragments as large as 95 kb |
| 05/21/1997 | EP0409928B1 Expression of proteinaceous sweeteners in yeast |
| 05/21/1997 | CN1150458A Hybrid molecule of formula GM-CSF-L-EPO or EPO-L-GM-CSF for hematopoietic stimulation |
| 05/21/1997 | CN1150457A Gene imparting flocculability to yeast and gene product |
| 05/21/1997 | CN1150433A Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 05/21/1997 | CN1150431A Purification of oligodeoxynucleotide phosphorothioates using anion exchange chromatography |
| 05/21/1997 | CN1150390A Glial mitogenic factors, their preparation and use |
| 05/21/1997 | CN1150177A Construction method of gene probe using chlorophyll molecule as connexon |
| 05/20/1997 | US5631407 Testing the efficacy of a vaccine to determine protection from infection by human picornavirus; genetic engineering |
| 05/20/1997 | US5631362 Forming dna and rna by polycondensation of mononucleotides with protective sulfonylalkyl dimethylaminonaphthalene groups for alkoxy furan groups |
| 05/20/1997 | US5631360 Multistage synthesis, treatment of nucleosides, adding a n-phthaloyl group, deprotecting the hydroxy, tritylation and phosphitylation |
| 05/20/1997 | US5631359 Hairpin ribozymes |
| 05/20/1997 | US5631358 Legume early nodulin gene; soybeans; genetic engineering |
| 05/20/1997 | US5631349 Chimeric monoclonal antibodies recognizing human interleukin-2-receptor |
| 05/20/1997 | US5631348 Protein sequence of the plant toxin gelonin |
| 05/20/1997 | US5631237 Fusion of liposomes containing sendai virus proteins to cell targets |
| 05/20/1997 | US5631236 Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
| 05/20/1997 | US5631228 Anti-fungal and anti-bacterial histatin-based peptides |
| 05/20/1997 | US5631162 Gene expression and dna sequences |
| 05/20/1997 | US5631158 Methods and compositions for high protein production from non-native DNA |
| 05/20/1997 | US5631157 Having a genetically engineered plasmid to impart stability during fermentation |
| 05/20/1997 | US5631156 Genetic engineering |
| 05/20/1997 | US5631154 Polypeptides, genetic engineering and assembly of defective viral particles |
| 05/20/1997 | US5631153 Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same |
| 05/20/1997 | US5631152 Rapid and efficient regeneration of transgenic plants |
| 05/20/1997 | US5631149 Variant-type carbohydrate hydrolase, variant gene of the enzyme and method for producing oligosaccharide using the enzyme |
| 05/20/1997 | US5631148 A catalytic region, a substrate binder region and a displaceable antisense arm for release of endonuclease cleavage fragments |
| 05/20/1997 | US5631146 DNA aptamers and catalysts that bind adenosine or adenosine-5'-phosphates and methods for isolation thereof |
| 05/20/1997 | US5631145 Biosynthesis, genetic engineering |
| 05/20/1997 | US5631144 Application of novel DNA fragments as a coding sequence for a signal peptide for the secretion of mature proteins by recombinant yeast, expression cassettes, transformed yeast and corresponding process for the preparation of proteins |
| 05/20/1997 | US5631143 K. lactis pyruvate-decarboxylase promoter and use thereof |
| 05/20/1997 | US5631137 Reaction-based selection for expression of and concentration of catalytic moieties |